C McAleer
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
-
- Prostate Cancer Treatment and Research
- Lung Cancer Treatments and Mutations
- Prostate Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 16
- Cancer Treatment and Pharmacology 9
- Lung Cancer Research Studies 5
- Cancer Cells and Metastasis 2
-
- Lung Cancer Treatments and Mutations 6
- Prostate Cancer Treatment and Research 2
- Co-authors
- Peter J. O’Dwyer (7 shared papers)Bruce J. Giantonio (6 shared papers)Corey J. Langer (8 shared papers)G. R. Hudes (4 shared papers)R F Ozols (3 shared papers)John Leighton (2 shared papers)P F Engstrom (2 shared papers)Robert L. Comis (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)Lung Cancer (4 papers)Investigational New Drugs (2 papers)Clinical Cancer Research (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
C McAleer
23 papers receiving 855 citations
Peers
Comparison fields: 5 of 67
- Oncology 368
- Pulmonary and Respiratory Medicine 371
- Cancer Research 112
- Hematology 40
- Immunology 66
Countries citing papers authored by C McAleer
This map shows the geographic impact of C McAleer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C McAleer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C McAleer more than expected).
Fields of papers citing papers by C McAleer
This network shows the impact of papers produced by C McAleer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C McAleer. The network helps show where C McAleer may publish in the future.
Co-authors
The 25 scholars most cited alongside C McAleer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 252 | |
| 2 | 1997 | 206 | |
| 3 | 1997 | 70 | |
| 4 | Paclitaxel plus estramustine in metastatic hormone-refractory prostate cancer. | 1995 | 59 |
| 5 | 2016 | 41 | |
| 6 | Superantigen-targeted therapy: phase I escalating repeat dose trial of the fusion protein PNU-214565 in patients with advanced gastrointestinal malignancies. | 1998 | 35 |
| 7 | 1995 | 29 | |
| 8 | 2002 | 29 | |
| 9 | Phase I study of paclitaxel and estramustine: preliminary activity in hormone-refractory prostate cancer. | 1995 | 25 |
| 10 | 2004 | 21 | |
| 11 | 1992 | 21 | |
| 12 | Phase I study of etoposide phosphate (etopophos) as a 30-minute infusion on days 1, 3, and 5. | 1995 | 19 |
| 13 | 1997 | 15 | |
| 14 | 2010 | 15 | |
| 15 | 1995 | 10 | |
| 16 | 2000 | 8 | |
| 17 | Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network. | 1997 | 8 |
| 18 | Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience. | 1995 | 8 |
| 19 | Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network. | 1996 | 6 |
| 20 | 1995 | 6 |
About C McAleer
C McAleer is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 23 papers that have together received 890 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (5 papers), Cancer Genomics and Diagnostics (2 papers), Prostate Cancer Treatment and Research (2 papers), Cancer therapeutics and mechanisms (2 papers), Cancer Research and Treatments (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Oncology (368 citations), Pulmonary and Respiratory Medicine (371 citations), Cancer Research (112 citations), Hematology (40 citations) and Immunology (66 citations). C McAleer has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Peter J. O’Dwyer, Bruce J. Giantonio, Corey J. Langer, G. R. Hudes, R F Ozols, John Leighton, P F Engstrom, Robert L. Comis, Samuel Litwin and Leonard G. Gomella. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Investigational New Drugs, Clinical Cancer Research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.